Consolidated Statement Of Profit Or Loss

Solasia Pharma K.K. - Filing #7311866

Concept 2024-01-01 to
2024-06-30
2024-01-01 to
2024-06-30
2024-01-01 to
2024-06-30
2024-01-01 to
2024-06-30
2024-01-01 to
2024-06-30
2024-04-01 to
2024-06-30
2024-01-01 to
2024-06-30
2024-01-01 to
2024-06-30
2024-01-01 to
2024-06-30
2023-01-01 to
2023-06-30
2023-01-01 to
2023-06-30
2023-01-01 to
2023-06-30
2023-01-01 to
2023-06-30
2023-01-01 to
2023-06-30
2023-01-01 to
2023-06-30
2023-01-01 to
2023-06-30
2023-04-01 to
2023-06-30
2023-01-01 to
2023-06-30
Consolidated statement of profit or loss
Statement of profit or loss
Revenue
72,000,000 JPY
60,000,000 JPY
529,000,000 JPY
309,000,000 JPY
Cost of sales
69,000,000 JPY
58,000,000 JPY
240,000,000 JPY
148,000,000 JPY
Gross profit
2,000,000 JPY
2,000,000 JPY
289,000,000 JPY
161,000,000 JPY
Selling, general and administrative expenses
390,000,000 JPY
158,000,000 JPY
559,000,000 JPY
279,000,000 JPY
Operating profit (loss)
-611,000,000 JPY
-303,000,000 JPY
-462,000,000 JPY
-217,000,000 JPY
Finance income
0 JPY
JPY
15,000,000 JPY
15,000,000 JPY
Finance costs
14,000,000 JPY
3,000,000 JPY
0 JPY
0 JPY
Share of profit (loss) of investments accounted for using equity method
-2,000,000 JPY
-1,000,000 JPY
-3,000,000 JPY
-1,000,000 JPY
Profit (loss) before tax
-627,000,000 JPY
-309,000,000 JPY
-450,000,000 JPY
-203,000,000 JPY
Income tax expense
-16,000,000 JPY
-8,000,000 JPY
-13,000,000 JPY
-6,000,000 JPY
Profit (loss)
JPY
-611,000,000 JPY
JPY
JPY
JPY
-300,000,000 JPY
JPY
JPY
-611,000,000 JPY
JPY
JPY
-437,000,000 JPY
JPY
JPY
JPY
-437,000,000 JPY
-196,000,000 JPY
JPY
Profit (loss) attributable to
Owners of parent
-611,000,000 JPY
-300,000,000 JPY
-437,000,000 JPY
-196,000,000 JPY
Earnings (loss) per share
Basic earnings (loss) per share
-3.35
-1.57
-2.61
-1.17
Diluted earnings (loss) per share
-3.35
-1.57
-2.61
-1.17

Talk to a Data Expert

Have a question? We'll get back to you promptly.